OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Drug discovery remains a very long and costly process with reducing attrition a major objective. We have shown previously that using human genetics evidence may increase the chance of success in the clinic for drug targets. In addition, genomics technologies that can measure omics layers or perturb the genome at scale can also be used to identify and validate new drug targets and investigate biology at a systems level. In this talk, using examples, I will describe how genetics and genomics data with computational biology analyses are currently being used in drug discovery and the importance of biological context.
